Sulfuric Acid → Salbutamol

HRID 48093

반응식

HRID 48093 반응식
S(=O)(=O)(O)O.[Cl-].[Na+].[CH3:8][C:9]([NH:12][CH2:13][CH:14]([OH:24])[C:15]1[CH:16]=[CH:17][C:18]([OH:23])=[C:19]([CH2:21][OH:22])[CH:20]=1)([CH3:11])[CH3:10].OS(O)(=O)=O>O>[CH3:11][C:9]([NH:12][CH2:13][CH:14]([OH:24])[C:15]1[CH:16]=[CH:17][C:18]([OH:23])=[C:19]([CH2:21][OH:22])[CH:20]=1)([CH3:8])[CH3:10]

참가 물질

5

반응물 3

HCID 1118Sulfuric AcidHCID 5234Sodium ChlorideHCID 9884233Salbutamol Sulfate

생성물 1

HCID 2083Salbutamol

시약·촉매·용매 1

HCID 962Water용매

실험 절차

In an alternative embodiment, the inhalation solution of the present invention may be prepared as follows: (i) fitting a high density polyethylene (HDPE) or stainless steel formulation tank with a bottom drain and peristaltic recirculation system (for HDPE) or tri-blender (for stainless steel) for mixing; (ii) filling the tank with approximately 90% of the required amount of Purified Water USP at a temperature of between 18° C. to 25° C.; while mixing, (iii) adding sulfuric acid, Sodium Chloride USP, and at least a therapeutically effective pediatric amount of Albuterol Sulfate USP to the tank; (iv) continue mixing until all chemical components are dissolved; (v) adding Purified Water USP to adjust the final volume, if necessary, thus producing an albuterol mixture.

후처리

  1. customIn an alternative embodiment, the inhalation solution of the present invention may be prepared
  2. additionfor mixing
  3. customof between 18° C. to 25° C.
  4. additionwhile mixing
  5. dissolutionare dissolved
  6. customPurified Water USP

출처 및 근거

ORD 기록
ord-5e22ad9c5cce42a49be1bce2ca1f9a58
출처 데이터셋
uspto-grants-2004_03
특허 번호
US06702997B2

연결된 노트

불러오는 중…